Get started
Author

Ernesto Ayala

ORCID: 0000-0002-4747-329X
Observed ORCID: 0000-0002-4747-329X
OpenAlex ID: A5082286704
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease
2026 · Ashish O. Gupta, Akshay Sharma, et al. · New England Journal of Medicine · 38
Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises
2024 · Ashish O. Gupta, Akshay Sharma, et al. · Blood · 17
Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BMS-986353 (CC-97540), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy Manufactured Using a Next-Generation Process, for Severe, Refractory Autoimmune Diseases: Updated Data from Ongoing Phase 1, Multicenter, Open-Label Studies
2024 · Fabian Mueller, Krish Patel, et al. · Blood · 4
PDF
Reply to “Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R ‐Related Leukoencephalopathy”
2022 · Philip W. Tipton, Daniel Kenney‐Jung, et al. · Movement Disorders · 3
Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi‐Centre Matched Analysis
2026 · Mohamed H. Eldesouki, Ahmed Ibrahim, et al. · Alimentary Pharmacology & Therapeutics · 2
Hematopoietic Stem Cell Transplantation for CSF1R-Related Disorder: A Longitudinal Study of Efficacy and Safety
2026 · Tomasz Chmiela, Kamila Żur-Wyrozumska, et al. · Journal of Movement Disorders · 2
PDF
Clinical Outcomes from the Pooled Safety Analysis of CD19 Nex-T™ (BMS-986353), a Chimeric Antigen Receptor (CAR) T cell Therapy Manufactured Using a Next-Generation Process, in Severe Refractory Autoimmune Diseases: Results from Phase 1 Breakfree Studies
2026 · Ran Reshef, Jacques Azzi, et al. · Transplantation and Cellular Therapy · 2
Peri-Transplant and Maintenance Daratumumab for Minimal Residual Disease (MRD) Eradication in Transplant-Eligible Multiple Myeloma (MM) Patients
2022 · Sikander Ailawadhi, Ricardo D Parrondo, et al. · Blood · 2
Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma
2024 · Yumeng Zhang, Ashley Rose, et al. · Transplantation and Cellular Therapy · 1
Protective Conditioning for Acute Graft-versus-Host Disease
2005 · Ernesto Ayala, Mohamed Kharfan-Dabaja · New England Journal of Medicine · 1
Survival and disease reactivation after autologous stem cell transplantation for systemic sclerosis: a single-centre cohort
2026 · Claire E Wilson, Rachel F Sauls, et al. · EULAR Rheumatology Open
Adopting a Standard of Care for Systemic Sclerosis: The Mayo Clinic Experience
2026 · Ernesto Ayala, Madiha Iqbal, et al. · Arthritis Care & Research
Comparative Efficacy of Donor Lymphocyte Infusions in Augmenting Graft-versus-Leukemia Effect after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myeloid Malignancies
2026 · Maymona Abdelmagid, Naima J. Hashi, et al. · Acta Haematologica
Bruton tyrosine kinase inhibitors in combination with chemoimmunotherapy is an effective treatment for patients with Richter’s syndrome
2026 · Tristan L'Esperance, Giovann Huynh, et al. · Leukemia Research Reports
Safety and efficacy of post transplant cyclophosphamide vs tacrolimus plus methotrexate for gvhd prophylaxis in myelofibrosis
2025 · Usman Ilyas, Carolyn Mead-Harvey, et al. · Blood
PDF
Effect of pre-allogeneic HCT splenic irradiation on post-transplant engraftment and outcomes in patients with myelofibrosis: A single-center experience
2025 · Yenny Moreno Vanegas, Ahmed Abdelhakeem, et al. · Blood
PDF
Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
2025 · Madiha Iqbal, Himil Mahadevia, et al. · Hematology/Oncology and Stem Cell Therapy
Safety and Efficacy of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) for the Treatment of Sickle Cell Disease with Severe Vaso-Occlusive Crises: Results from the Ongoing Phase 1/2 Beacon Study
2025 · Ashish O. Gupta, Akshay Sharma, et al. · Transplantation and Cellular Therapy
Microvascular remodeling after autologous stem cell transplant in an overlap of systemic sclerosis and systemic lupus erythematosus: A case report
2024 · Sehreen Mumtaz, Lisa M Balistreri, et al. · SAGE Open Medical Case Reports
Autologous Hematopoietic Cell Transplant Consolidation for First Response Is Associated with Longer Survival in Patients with Nodal Peripheral T-Cell Lymphoma
2022 · Yumeng Zhang, Ashley Rose, et al. · Blood
Comparing Survival Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Nodal Peripheral T-Cell Lymphoma
2022 · Yumeng Zhang, Jennifer Eatrides, et al. · Blood
Works count: 21
Citation count: 72
H-index: 3
I10-index: 2
Year
Topic
Type